Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

37
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

46
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

420
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
420
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

25
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
25
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

765
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
765

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunoadsorption in dilated cardiomyopathy: the IASO-DCM trial.

European heart journal·2026
Same author

Baseline characteristics in the TransitionCHF study: asymptomatic patients with heart failure and reduced ejection fraction.

ESC heart failure·2026
Same author

Urinary Dickkopf-3 as a Potential Marker for Estimated Glomerular Filtration Rate Decline in Patients With Heart Failure.

Journal of the American Heart Association·2024
Same author

Diabetes mellitus is associated with low exercise capacity and impaired peripheral vasodilation in patients with heart failure - a propensity score-matched study.

Diabetes research and clinical practice·2024
Same author

Transition from asymptomatic to symptomatic systolic chronic heart failure: rationale and design of TransitionCHF.

ESC heart failure·2024
Same author

Increased Expression of Proinflammatory Genes in Peripheral Blood Cells Is Associated with Cardiac Cachexia in Patients with Heart Failure with Reduced Ejection Fraction.

Journal of clinical medicine·2024
Same journal

Innere Medizin (Heidelberg, Germany)·2026
Same journal

Innere Medizin (Heidelberg, Germany)·2026
Same journal

Innere Medizin (Heidelberg, Germany)·2026
Same journal

[Optimal blood pressure control in patients with diabetes and arterial hypertension: interpreting the BPROAD study].

Innere Medizin (Heidelberg, Germany)·2026
Same journal

[Distributive justice in healthcare during times of change: a medical ethics perspective].

Innere Medizin (Heidelberg, Germany)·2026
Same journal

[Update on the pharmacotherapy of chronic heart failure with reduced ejection fraction: from four to six pillars?]

Innere Medizin (Heidelberg, Germany)·2026
See all related articles

Related Experiment Video

Updated: Aug 19, 2025

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways
10:44

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways

Published on: December 9, 2013

12.1K

[Gender-specific differences in cardiology].

Anja Sandek1,2, Gerd Hasenfuß3,4

  • 1Herzzentrum Göttingen, Klinik für Kardiologie und Pneumologie, Universitätsmedizin Göttingen, Georg-August-Universität, Robert-Koch-Str. 40, 37075, Göttingen, Deutschland. anja.sandek@med.uni-goettingen.de.

Innere Medizin (Heidelberg, Germany)
|December 1, 2022
PubMed
Summary
This summary is machine-generated.

Cardiovascular disease (CVD) care is biased against women. Research highlights gender-specific differences in CVD, necessitating tailored treatments for better outcomes.

Keywords:
Cardiovascular diseases/epidemiologyCardiovascular diseases/pathophysiologyCardiovascular diseases/treatmentCardiovascular risk factorsGender-specific studies

More Related Videos

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
12:37

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

13.5K
Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects
06:57

Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects

Published on: February 12, 2021

3.3K

Related Experiment Videos

Last Updated: Aug 19, 2025

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways
10:44

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways

Published on: December 9, 2013

12.1K
Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
12:37

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

13.5K
Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects
06:57

Effects of Surgical Masks on Cardiopulmonary Function in Healthy Subjects

Published on: February 12, 2021

3.3K

Area of Science:

  • Cardiology
  • Gender Medicine
  • Clinical Research

Context:

  • Current cardiovascular patient care disproportionately affects women.
  • Existing evidence on cardiovascular diseases (CVDs) often overlooks gender-specific aspects.
  • A gender-specific approach is crucial for equitable healthcare.

Purpose:

  • To summarize current knowledge on gender differences in cardiovascular diseases (CVDs).
  • To focus on epidemiology, pathophysiology, risk factors, and treatment in women.
  • To highlight the need for gender-specific analysis in clinical trials.

Summary:

  • Increasing evidence points to unique pathogenic mechanisms in women.
  • Pharmacodynamic and pharmacokinetic variations exist between sexes.
  • Women are less likely to receive guideline-recommended cardiac treatments compared to men.

Impact:

  • Investigating female-specific pathogenetic mechanisms is vital for improving CVD treatment.
  • Enhanced understanding can lead to more effective disease prevention strategies for women.
  • Promotes gender equity in cardiovascular medicine.